Clinical Trials Logo

Common Cold clinical trials

View clinical trials related to Common Cold.

Filter by:

NCT ID: NCT04002349 Recruiting - Clinical trials for Impact of Different Medications on Biomarkers of Idiopathic Rhinitis

Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Chronic rhinitis (CR) is one of the most common nasal mucosal diseases in the world. In China, about 140 million people suffer from this disease. Chronic rhinitis can lead to severe economic and social burden, as well as the potential risk of developing other chronic diseases such as asthma and chronic sinusitis. Therefore, it is of great significance to explore the classification and treatment strategies of chronic rhinitis in order to improve the health level of Chinese people.

NCT ID: NCT01744106 Recruiting - Clinical trials for Nasal Congestion Associated With the Common Cold

A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold

Start date: November 2012
Phase: Phase 3
Study type: Interventional

This study is designed to confirm the effectiveness of single-ingredient pseudoephedrine in children for the temporary relief of nasal congestion due to the common cold, an indication described under 21 CFR 341.80(b)(1).

NCT ID: NCT01651663 Recruiting - Influenza Clinical Trials

A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold

ARBITR
Start date: September 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether Arbidol (Umifenovir) is effective in the treatment and Prophylaxis of Influenza and Common Cold

NCT ID: NCT00940836 Recruiting - Common Cold Clinical Trials

Efficacy and Safety Assessment of an Anti-Cold Preparation in the Symptomatic Treatment of Common Cold and Flu-Like Syndrome

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The aim of this study is to assess the efficacy and safety of an anti-cold preparation compounded by acetaminophen, chlorpheniramine and phenylephrine for the treatment of cold and flu symptoms in healthy individuals in a randomized, double-blind, placebo-controlled clinical trial.